MedPath

Risperdal

Brand Name: Risperdal

Generic Name: Risperidone

Active
Registration Number

DR-XY24871

Dosage Form

Oral Solution

Issuance Date

December 16, 2021

Expiry Date

November 13, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1mg/ mL
PackagingUSP type III amber glass bottle x 30mL w/ plastic child-resistant closure (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antipsychotic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

RisperidoneActive
Monograph: Risperidone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform